Seham Noureldin

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

Jordan J. Feld, Christopher Kandel, Mia J. Biondi et al. · The Lancet Respiratory Medicine · 2021 · 237 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine

Bianca M. Arendt, David W.L., Brigitte Simons et al. · Applied Physiology Nutrition and Metabolism · 2013 · 160 citations · Full text

Life Sciences, Biochemistry, Hepatology +16

Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)

Kin Seng Liem, Scott Fung, David Wong et al. · Gut · 2019 · 143 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A Cross-Sectional Study Assessing Dietary Intake and Physical Activity in Canadian Patients with Nonalcoholic Fatty Liver Disease vs Healthy Controls

Hannah E. Da Silva, Bianca M. Arendt, Seham Noureldin et al. · Journal of the Academy of Nutrition and Dietetics · 2014 · 86 citations

Agriculture, Nutrition, Nutritional Sciences +13

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · Annals of Internal Medicine · 2023 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17